Published 1997 | Version v1
Miscellaneous

Comparison of acetazolamide-enhanced brain SPECT using Tc-99m ECD with cerebral angiography in patients with cerebrovascular disease

  • 1. College of Medicine, Hanyang Univ., Seoul (Korea, Republic of)
  • 2. Asan Medical Cener, Seoul (Korea, Republic of)

Description

Cerebral vascular reserve can be assessed by development of collateral channels (DCC) on cerebral angiography(CA) or vasoreactivity (VR) on acetazolamide-enhanced brain SPECT (ACZ-SPECT). The purpose of this study was to compare Tc-99m ECD ACZ-SPECT with CA in the evaluation of vascular reserve in patients (pts) with cerebrovascular disease(CVD). Twenty seven patients with CVD, including TIA (n=13), infarction (n=11) and asymptomatic pts (AS, n=3), underwent CA and ACZ-SPECT. Basal and ACZ-SPECT was obtained consecutively, and image subtraction was performed. On CA, degree of DCC was scored 0-3 (0: normal, 3: poor) according to parenchymal staining on delayed film. In ACZ-SPECT, decrease of VR was graded 0-3 (0: normal, 3: more than 30% decrease). The correlation between degree of stenosis, DCC and VR were analyzed. 1) Variable degree of VR or DCC was observed in totally occluded or stenotic cerebral arterial territories. 2) In arterial territories with poor DCC, ACZ-SPECT showed poor VR. However, in 5 out of 11 TIA or AS with good DCC, poor VR was observed. These data suggests that 1) cerebral hemodynamic status cannot be assessed by the degree of stenosis on CA alone. 2) DCC may overestimate the cerebral vascular reserve in patients with TIA or AS. 3) ACZ-SPECT plays a complementary role to CA for evaluation of cerebral hemodynamic status in pts with CVD

Part of:
Proceedings of the Korean Society Nuclear Medicine Spring Meeting 1997

Additional details

Publishing Information

Publisher
KSNM
Imprint Place
Seoul (Korea, Republic of)
Imprint Title
Proceedings of the Korean Society Nuclear Medicine Spring Meeting 1997
Imprint Pagination
[792 p.]
Journal Page Range
[4 p.]

Conference

Title
36. Annual Spring Meeting of the Korean Society Nuclear Medicine
Dates
16-17 May 1997
Place
Seoul (Korea, Republic of)

Optional Information

Notes
7 refs